Navigation Links
Personalized AF management needed to close mortality gap
Date:8/27/2013

Amsterdam, The Netherlands Tuesday 27 August 2013: Personalised management is the only way to close the mortality gap for patients with atrial fibrillation (AF), according to an ESC consensus paper presented at ESC Congress 2013 by Professor Paulus Kirchhof (UK).

The Atrial Fibrillation competence NETwork (AFNET) and European Heart Rhythm Association (EHRA) consensus paper is published online in the European Journal of Pacing, Arrhythmias, and Cardiac Electrophysiology (EP-Europace)1 and presented during the ESC Congress session on personalised cardiology.

Professor Kirchhof said: "Acute and 1-year mortality after myocardial infarction has dropped by two-thirds in the last 10 to 15 years primarily because of medical interventions aimed at the principal pathophysiology causing the disease. For example acute revascularization procedures are used to treat a thrombotic blockage of the artery while statins prevent the development and rupture of coronary plaques."

But he added: "We are in an intermediate position with AF. With the introduction of oral anticoagulant therapy we can prevent about two-thirds of all strokes in AF. But patients with AF still have a higher mortality compared to their age and cardiovascular risk matched peers without AF, and we are not able to reduce that mortality by much even when we apply all the evidence based therapies."2,3

The fourth AFNET/EHRA consensus conference was convened to discuss how to identify the underlying main pathophysiologies of AF in individual patients so that more targeted therapies could be developed to close the mortality gap. Professor Kirchhof said: "This requires understanding the disease mechanisms and translating them into parameters we can measure in patients. This is particularly difficult for AF because the left atrium is a small part of the heart located posteriorly in the body and difficult to access."

A certain degree of personalisation is already practised in AF. Stroke risk scores based on clinically measurable risk factors aid decisions on anticoagulant therapy while the severity of AF symptoms help to determine rhythm control therapy.

The consensus paper identifies three main ways to better characterise the underlying cause of AF in order to improve treatment: the electrocardiogram (ECG); imaging, especially echocardiography and magnetic resonance imaging (MRI); and biomarkers (proteins or genes measured in blood to identify the type of AF).

A new taxonomy of AF is proposed based on its pathophysiology. Professor Kirchhof said: "The classification is imperfect because there are overlaps between categories and the majority of AF patients fall into the 'unclassified AF' group. But it illustrates that we need a better understanding of why AF develops in an individual patient before we can classify them based on biomarkers, imaging or ECG, in addition to clinical parameters, and develop better therapies."

He added: "The hope is that within the next few years we will be able to propose personalised management of AF and thereby reduce the excess mortality associated with the disease."

Professor Kirchhof continued: "There is still plenty of room to improve the management of AF even if we apply all the evidence based therapies currently available for example the new oral anticoagulants have improved mortality by just 5-10%. And every fourth patient with AF is admitted to hospital at least once a year due to AF, which illustrates the high morbidity and healthcare costs associated with the disease."

He concluded: "This is the first European consensus document on personalised management of AF, which is the most promising way to further improve morbidity and mortality in AF patients."


'/>"/>

Contact: Press Office
press@escardio.org
European Society of Cardiology
Source:Eurekalert

Related medicine news :

1. Figurella Offers Natural and Personalized Weight Loss at Two Florida Locations
2. Global Personalized Medicine and Companion Diagnostic Market Q2 2013 - A Strategic Analysis of Industry Trends, Technologies, Participants and Environment Research Report
3. hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Moderation for Dieters with New Personalized Nutrition Plans
4. Woman Was Able to Stop the Development of Diabetes in a Personalized Prediabetes Treatment Program
5. Software toolkit shapes models for personalized radionuclide therapy
6. JumperCut Launches Personalized Video Platform to Drive Patient Engagement
7. The Perfect Fit Knee: Personalized Knee Replacement Implants Are Here
8. CureLauncher Introduces Personalized Clinical Trial Matching Service
9. Amirsys AnatomyOne 2.0 Delivers Personalized Learning Plans
10. hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce Improved, Personalized Diet Plans to Create a Healthy Lifestyle Change and Lose Weight Fast
11. Katixon Announces Personalized Sustainable and Natural Anti-Aging Skin Cream To Their Product Lineup
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: